Galapagos NV GLPG

Quarterly report 2025-Q4
added 05-06-2026

Galapagos NV DIO Ratio 2011-2026 | GLPG

Annual DIO Ratio Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	0.915	0.923	2.2	1.55	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
2.2	0.915	1.4

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Happiness Biotech Group Limited HAPP	1.91 K	-	1.35 %	$ 17.8 M	China
	Coherus BioSciences CHRS	97.5	$ 1.64	-	$ 192 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Esperion Therapeutics ESPR	2.46 K	$ 3.12	-	$ 649 M	USA
	Eton Pharmaceuticals ETON	150	$ 31.29	-	$ 842 M	USA
	Affimed N.V. AFMD	69.8	-	-34.95 %	$ 21.5 M	Germany
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Grifols, S.A. GRFS	0.000171	$ 8.01	-	$ 5.44 B	Spain
	Hutchison China MediTech Limited HCM	49.7	$ 11.75	-	$ 10.1 B	China
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Heron Therapeutics HRTX	644	$ 0.88	-	$ 147 M	USA
	Anika Therapeutics ANIK	159	$ 14.89	-	$ 214 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA